Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (411)	8/25/1999 3:10:00 PM
From: RCMac	Read Replies (2) \| Respond to of 626

Dave, The warrants expire in January 2001: Message 7371893 The strike price of $6.20 was later revised downward to $6.02 in connection with a (slightly dilutive) financing late last January. Selling the stock and buying the warrants sounds sensible to me as well, although I don't have to think about it in detail since I also hold just the warrants. The warrants are less liquid, though -- when I bought in mid-January, in the three trading days after Novartis announced the expansion of the Phase III Iloperidone trial (a $100 million+ vote of confidence), my purchases of 6000 warrants for about $3700 represented just under a third of the volume! A bit more liquid now. --RCM